Canada markets close in 5 hours 41 minutes

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5700-0.0200 (-0.44%)
As of 10:08AM EDT. Market open.

Relmada Therapeutics, Inc.

2222 Ponce de Leon Boulevard
Floor 3
Coral Gables, FL 33134
United States
786 629 1376
https://www.relmada.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees20

Key Executives

NameTitlePayExercisedYear Born
Dr. Sergio Traversa M.B.A., Pharm.D.CEO & Director719.04kN/A1960
Mr. Maged S. Shenouda M.B.A., R.Ph.Chief Financial Officer450.35kN/A1964
Mr. Charles S. Ence CPA, M.B.A.Chief Accounting & Compliance Officer568.68kN/A1965
Dr. Paolo Manfredi M.D., Ph.D.Chief Scientific OfficerN/AN/A1962
Ms. Gina DiGuglielmoVP & Head of Clinical OperationsN/AN/AN/A
Dr. Marco Pappagallo M.D.Chief Clinical OfficerN/AN/A1959
Mr. John HixonHead of CommercialN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Corporate Governance

Relmada Therapeutics, Inc.’s ISS Governance QualityScore as of March 1, 2024 is 9. The pillar scores are Audit: 6; Board: 10; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.